‘Transferable job skills just meant communication skills.’

“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.”

“What skills stand out on Biotechnologist resumes?”

Are we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry?

The Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy, and one of the country’s fastest-growing industries. Across Canada, 33% of biotechnology and life sciences, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library).

Ready to take this challenge and have the thirst to learn more?

Join this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan, who will share her experiences.

Agenda:

• Welcome Remarks – IWS Network

• Introduction of AdMare

• Speaker session

• Virtual networking

About the Speaker:

Dr. Edie Dullaghan, Scientific Director, adMare Academy, adMare BioInnovations, Vancouver, BC

As the Scientific Director of the adMare Academy, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare, Dr. Dullaghan supports the Academy’s programs, including The BioInnovation Scientist Program, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry.

Previously, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc., developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career, she has managed several large-scale R&D programs, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens.

Dr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis, the causative agent of TB.